Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Dipanjan Banchur

HISTORICAL FACTS: 3 biotech stocks poised to outperform in 2022 - The Untold Story

The COVID-19 pandemic highlighted the limitations of the global healthcare sector. Since its advent, governments worldwide have been investing heavily in their nations’ healthcare industries to mitigate the public health crisis. Thus, the popularity of biotechnology stocks with investors has increased dramatically since March 2020, given the sector’s key role in ameliorating the virus’ effects.

Scientific advances in biotechnology have created new ways of treating and preventing many diseases. The pandemic drove biotechnology companies to expeditiously develop treatments and vaccines for the COVID-19 virus. And with the virus continuing to mutate into newer variants, biotechnology companies will again be in focus as the demand for booster doses and therapies grows. According to a Qualiket Research report, the global biotechnology market is expected to grow at a 15.5% CAGR through 2027. And biotech companies are also providing products and technologies to combat other debilitating and rare diseases.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.